Malcolm MacEachern Symposium 2019

henry and allison mcCance PRofessor of business administration, harvard business school
Malcolm wiener professor of social policy and Director of health policy research, harvard kennedy school of government


Professor Chandra is a member of the Congressional Budget Office's (CBO) Panel of Health Advisors, and is a Research Associate at the National Bureau of Economic Research (NBER). His research focuses on innovation and pricing in the biopharmaceutical industry, value in health care, medical malpractice, and racial disparities in healthcare. His research has been supported by the National Institute of Aging, the National Institute of Child Health and Development, the Robert Wood Johnson Foundation, and has been published in the American Economic Review, the Journal of Political Economy, the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is the Chair Editor of the Review of Economics and Statistics.

Chandra has testified to the United States Senate and the United States Commission on Civil Rights. His research has been featured in the New York Times, the Washington Post, CNN, Newsweek, and on National Public Radio. He has been a consultant to the RAND Corporation, Microsoft Research and the Blue Cross Blue Shield Foundation of Massachusetts. In 2011 he served as Massachusetts' Special Commissioner on Provider Price Reform.

Professor Chandra is an elected member of the National Academy of Medicine, the first-prize recipient of the Upjohn Institute's Dissertation Award, the NIHCM Foundation Health Care Research Award, the Kenneth Arrow Award for best paper in health economics, and the Eugene Garfield Award for the impact of medical research. In 2012, he was awarded American Society of Health Economists (ASHE) medal. The ASHE Medal is awarded biennially to the economist age 40 or under who has made the most significant contributions to the field of health economics.

Walter J. McNerney Professor of Health Industry Management

David Dranove is the Walter McNerney Distinguished Professor of Health Industry Management at Northwestern University's Kellogg School of Management, where he is also Professor of Strategy.  He was previously Director of the Health Enterprise Management program. He has a PhD in Economics from Stanford University.

Associate Professor of Strategy, Director , healthcare at Kellogg, Northwestern University, Kellogg School of Management

Professor Garthwaite is the Herman R. Smith Research Professor in Hospital and Health Service, an Associate Professor of Strategy, and the Director of the Program on Healthcare at Kellogg (HCAK). He is an applied microeconomist whose research examines the effects of government policies and social phenomena with a focus on health and biopharmaceutical sectors. His recent work has focused on the private sector effects of the Affordable Care Act, including the labor supply effects of large insurance expansions, the changes in uncompensated hospital care resulting from public insurance expansions, and the responses of non-profit hospitals to financial shocks. In prior work, he has examined the impact of government cash assistance programs on health and the effect of changes in expected mortality from the emergence of crack-cocaine markets on educational attainment.

Charles E. & Susan T. Harris Professor, MIT sloan school of Management
Director, MIT's Laboratory for Financial Engineering
Principal investigator, MIT's Computer Science and ARtificial intelligence laboratory

Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of MIT’s Laboratory for Financial Engineering, and principal investigator at MIT's Computer Science and Artificial Intelligence Laboratory. His research interests include innovative approaches to healthcare financing and new statistical methods for incorporating patient preferences into the drug approval process and predicting clinical trial outcomes. Dr. Lo is the author of several books and over 100 articles, including “Commercializing Biomedical Research Through Securitization Techniques”, “Estimating Clinical Trial Success Rates and Related Parameters”, and “Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans”. Dr. Lo is a board member of the Whitehead Institute for Biomedical Research and Roivant Sciences, an advisor to BridgeBio Capital, and a member of the Board of Overseers at Beth Israel Deaconess Medical Center. Dr. Lo received his B.A. in economics from Yale University and his A.M. and Ph.D. in economics from Harvard University.

Former CEO & President, Gilead

Chief executive officer, Optumrx

John Prince currently serves as the chief executive officer of OptumRx, an industry-leading provider of pharmacy care services. In this capacity, his primary responsibilities include management of pharmacy benefits, pharmacy network, home delivery pharmacy, specialty pharmacy, home infusion, and workers’ compensation and auto no-fault solutions programs on behalf of clients and more than 65 million members.
Previously, Prince served as executive vice president and chief operating officer of Optum. He has held numerous roles with UnitedHealth Group since 2005, including executive vice president and chief financial officer of Optum; the first chief operating officer of OptumHealth; and led the formation of OptumHealthFinancial Services as its chief executive officer.
Prior to joining UnitedHealth Group, Prince served as senior vice president and head of health care business development and strategy at JPMorgan Chase and was a partner in Arthur Andersen’s health care strategy and operations practice.
Prince holds an undergraduate degree in economics and mathematics from Northwestern University, as well as an M.B.A from Northwestern’sKellogg School of Management. He serves on the board of the Pharmaceutical Care Management Association, The Executives’ Club of Chicago, and is actively involved with the Minneapolis Institute of Arts.

Evlin R. Latty PRofessor of LAw and co-director, the center for innovation policy, duke university law school

Arti Rai, Elvin R. Latty Professor of Law and co-Director, The Center for Innovation Policy at Duke Law, is an internationally recognized expert in intellectual property (IP) law, innovation policy, administrative law, and health law. Rai's research on innovation law and policy in biotechnology, pharmaceuticals, and software has been funded by NIH, the Kauffman Foundation, and the Woodrow Wilson Center. She is the editor of Intellectual Property Law and Biotechnology: Critical Concepts (Edward Elgar, 2011) and the co-author of a 2012 Kauffman Foundation monograph on cost-effective health care innovation.

Rai has served as the chief policy advisor to the Director of the U.S. Patent and Trademark Office; a member of the National Advisory Council for Human Genome Research; and as a public member of the Administrative Conference of the United States. Rai has also served on, or as a reviewer for, numerous National Academies of Science committees. In 2013, she was elected to the American Law Institute. She won the World Technology Network Award for Law in 2011.
Rai graduated from Harvard College with a degree in biochemistry and history (history and science), attended Harvard Medical School, and received her J.D. from Harvard Law School.

Associate Professor of Strategy, Northwestern University, Kellogg School of Management

Amanda Starc, Ph.D., is an Associate Professor of Strategy at the Kellogg School of Management and a Faculty Research Fellow at the National Bureau of Economic Research (NBER). She received her BA in Economics from Case Western Reserve University, and her PhD in Business Economics from Harvard University. Dr. Starc's research interests include industrial organization and health economics.

Her research examines the Medicare Advantage, Medicare Part D, and Medicare Supplement ("Medigap") markets, as well as consumer behavior in insurance exchanges. Recent work measures the effectiveness of direct-to-consumer advertising of pharmaceuticals. Her work links models of consumer choice and supply side incentives, and uses a range of econometric techniques to analyze data.